T_STEM-Like CAR-T Cells Exhibit Improved Persistence and Tumor Control Compared with Conventional CAR-T Cells in Preclinical Models

Scientists demonstrated that functional stem-like T (TSTEM) cells were less abundant in infused CAR-T cell products in a phase I clinical trial testing Lewis Y-CAR-T cells, and the infused CAR-T cells displayed poor persistence in patients.